9
|
dos Santos EDA, Hamel E, Bai R, Burnett JC, Tozatti CSS, Bogo D, Perdomo RT, Antunes AMM, Marques MM, Matos MDFC, de Lima DP. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. Bioorg Med Chem Lett 2013; 23:4669-73. [PMID: 23810282 PMCID: PMC3774136 DOI: 10.1016/j.bmcl.2013.06.009] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2013] [Revised: 05/27/2013] [Accepted: 06/03/2013] [Indexed: 12/12/2022]
Abstract
We have devised a procedure for the synthesis of analogs of combretastatin A-4 (CA-4) containing sulfur and selenium atoms as spacer groups between the aromatic rings. CA-4 is well known for its potent activity as an inhibitor of tubulin polymerization, and its prodrugs combretastatin A-4 phosphate (CA-4P) and combretastatin A-1 phosphate (CA-1P) are being investigated as antitumor agents that cause tumor vascular collapse in addition to their activity as cytotoxic compounds. Here we report the preparation of two sulfur analogs and one selenium analog of CA-4. All synthesized compounds, as well as several synthetic intermediates, were evaluated for inhibition of tubulin polymerization and for cytotoxic activity in human cancer cells. Compounds 3 and 4 were active at nM concentration against MCF-7 breast cancer cells. As inhibitors of tubulin polymerization, both 3 and 4 were more active than CA-4 itself. In addition, 4 was the most active of these agents against 786, HT-29 and PC-3 cancer cells. Molecular modeling binding studies are also reported for compounds 1, 3, 4 and CA-4 to tubulin within the colchicine site.
Collapse
Affiliation(s)
- Edson dos A. dos Santos
- Universidade Federal de Mato Grosso do Sul, Instituto de Química, Laboratório LP4, Av. Filinto Müller, 1555, 79070-900 Campo Grande (MS), Brazil
| | - Ernest Hamel
- Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research (FNLCR), National Cancer Institute (NCI), Frederick, MD 21702, USA
| | - Ruoli Bai
- Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research (FNLCR), National Cancer Institute (NCI), Frederick, MD 21702, USA
| | - James C. Burnett
- Computational Drug Development Group, Developmental Therapeutics Program, FNLCR, NCI, Frederick, MD 21702, USA
| | - Camila Santos Suniga Tozatti
- Universidade Federal de Mato Grosso do Sul, Instituto de Química, Laboratório LP4, Av. Filinto Müller, 1555, 79070-900 Campo Grande (MS), Brazil
| | - Danielle Bogo
- Universidade Federal de Mato Grosso do Sul, Laboratório de Biologia Molecular e Culturas Celulares-CCBS, CP 549, 79070-900 Campo Grande (MS), Brazil
| | - Renata T. Perdomo
- Universidade Federal de Mato Grosso do Sul, Laboratório de Biologia Molecular e Culturas Celulares-CCBS, CP 549, 79070-900 Campo Grande (MS), Brazil
| | - Alexandra M. M. Antunes
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, Portugal
| | - M. Matilde Marques
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, Portugal
| | - Maria de F. C. Matos
- Universidade Federal de Mato Grosso do Sul, Laboratório de Biologia Molecular e Culturas Celulares-CCBS, CP 549, 79070-900 Campo Grande (MS), Brazil
| | - Dênis P. de Lima
- Universidade Federal de Mato Grosso do Sul, Instituto de Química, Laboratório LP4, Av. Filinto Müller, 1555, 79070-900 Campo Grande (MS), Brazil
| |
Collapse
|
13
|
Busacca CA, Cerreta M, Dong Y, Eriksson MC, Farina V, Feng X, Kim JY, Lorenz JC, Sarvestani M, Simpson R, Varsolona R, Vitous J, Campbell SJ, Davis MS, Jones PJ, Norwood D, Qiu F, Beaulieu PL, Duceppe JS, Haché B, Brong J, Chiu FT, Curtis T, Kelley J, Lo YS, Powner TH. Development of a Pilot-Plant Process for a Nevirapine Analogue HIV NNRT Inhibitor. Org Process Res Dev 2008. [DOI: 10.1021/op8000756] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Carl A. Busacca
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Mike Cerreta
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Yong Dong
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Magnus C. Eriksson
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Vittorio Farina
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - XuWu Feng
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Ji-Young Kim
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Jon C. Lorenz
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Max Sarvestani
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Robert Simpson
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Rich Varsolona
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Jana Vitous
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Scot J. Campbell
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Mark S. Davis
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Paul-James Jones
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Daniel Norwood
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Fenghe Qiu
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Pierre L. Beaulieu
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Jean-Simon Duceppe
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Bruno Haché
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Jim Brong
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Fang-Ting Chiu
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Tom Curtis
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Jason Kelley
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Young S. Lo
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| | - Tory H. Powner
- Department of Analytical Sciences and Department of Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, U.S.A., Boehringer-Ingelheim Canada Limited, 2100 Cunard Street, Laval, Quebec H7S 2G5 Canada, and Boehringer-Ingelheim Chemicals Inc., 2820 North Normandy Drive, Petersburg, Virginia 23805, U.S.A
| |
Collapse
|